Abstract
Propionyl-L-carnitine protects ischemic myocardium in the isolated working rat heart preparation [1] and enhances recovery of myocardial function following mild myocardial ischemia in an in vivo porcine model [2]. The enhanced recovery of post-ischemic myocardium has been ascribed to a positive inotropic action of the drug [2]. Stimulation with catecholamines will also improve function of depressed post-ischemic (“stunned”) myocardium [3, 4], but this is accompanied by a shift in substrate utilization in favor of free fatty acids [4, 5]. Free fatty acid oxidation could, however, still be impaired because of a carnitine deficiency, depletion of mitochondrial pools of citric acid cycle intermediates and fatty acyl-CoA inhibition-induced adenine nucleotide translocation across the inner mitochondrial membrane. Propionyl-L-carnitine administration has the potential to relieve the deficiency of carnitine, to supply propionyl-CoA as a source of succinyl-CoA and to reduce fatty acyl- CoA accumulation (as we discussed in [6]). In this respect it is of interest that carnitine has increased the tolerance to pacing-induced myocardial ischemia in patients undergoing diagnostic cardiac catheterization [7]. Thus, propionyl-L-carnitine could, because of its metabolic actions, be useful during inotropic stimulation of post-ischemic myocardium with catecholamines.
“Post-ischemic blood flow to the myocardium perfused by the left anterior descending coronary artery was higher in the propionyl-L-carnitine-treated than in the untreated animals. It has been well established that reperfusion after a prolonged period of myocardial ischemia does not always result in a complete return of blood flow since the vasculature of the ischemic myocardium can become obstructed by extravascular compression or by intravascular obstructions (the “no-reflow”-phenomenon). It could then be argued that propionyl-L-carnitine treatment attenuated this no-reflow phenomenon.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL. Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 1986; 20: 536–541.
Liedtke AJ, DeMaison L, Nellis SH. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988; 255: H169–H176.
Becker LC, Levine JH, DiPaula AF, Guarnieri T, Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986; 7: 580–589.
McFalls EO, Duncker DJ, Krams R, Sassen LMA, Hoogendoorn A, Verdouw PD. Recruitment of myocardial work and metabolism in regionally stunned porcine myocardium. Am J Physiol 1992; 263: H1724–H1731.
Van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992; 72: 881–940.
Duncker DJ, Sassen LMA, Bartels GL et al. L-Propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetitive ischemia in anesthetized pigs. J Cardiovasc Pharmacol 1993; 22: 488–498.
Thomson JH, Shug AL, Yap VU, Patel AK, Karras TJ, DeFelice SL. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol 1979; 43: 300–306.
Sassen LMA, Bezstarosti K, Van der Giessen WJ, Lamers JMJ, Verdouw PD. L-propionylcarnitine increases post-ischemic blood flow but does not affect recovery of the energy charge. Am J Physiol 1991; 261: H172–H180.
Sassen LMA, Duncker DJ, Hogendoorn A et al. L-propionylcarnitine and myocardial performance in stunned porcine myocardium. Mol Cell Biochem 1992; 116: 147–153.
Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496–1508.
Hülsmann WC. Biochemical profile of propionyl-L-carnitine. Cardiovasc Drugs Ther 1991; 5(Suppl 1): 7–9.
Van Hinsberg VWM, Scheffer MA. Effect of propionyl-L-carnitine on human endothelial cells. Cardiovasc Drugs Ther 1991; 5(Suppl 1): 97–105.
Post JA, Lamers JMJ, Verdouw PD, Ten Cate FJ, Van der Giessen WJ, Verkleij AJ. Sarcolemmal destabilization and destruction after ischaemia and reperfusion and its relation with long-term recovery of regional left ventricular function in pigs. Eur Heart J 1987; 8: 423–430.
Van der Giessen WJ, Verdouw PD, Ten Cate FJ, Essed CE, Rijsterborgh H, Lamers JMJ. In vitro cyclic AMP induced phosphorylation of phospholamban: an early marker of long-term recovery of function following reperfusion of ischaemic myocardium? Basic Res Cardiol 1988; 10: 714–718.
Arnold JMO, Braunwald E, Sandor T, Kloner RA. Inotropic stimulation of reperfused myocardium with dopamine: Effects on infarct size and myocardial function. J Am Coll Cardiol 1985; 6: 1026–1034.
Van der Giessen WJ, Schoutsen B, Tijssen JGP, Verdouw PD. Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig. Br J Pharmacol 1986; 87: 23–27.
Ferrari R, Ceconi C, Curello S, Pasini E, Visioli O. Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. Mol Cell Biochem 1989; 88: 161–168.
Di Lisa F, Menabö R, Siliprandi N. L-propionyl-carnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem 1989; 88: 169–173.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Verdouw, P.D., Sassen, L.M.A., Duncker, D.J., Lamers, J.M.J. (1995). Dissociation of hemodynamic and metabolic effects of propionyl-L-carnitine in ischemic pig heart. In: De Jong, J.W., Ferrari, R. (eds) The Carnitine System. Developments in Cardiovascular Medicine, vol 162. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0275-9_21
Download citation
DOI: https://doi.org/10.1007/978-94-011-0275-9_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4122-5
Online ISBN: 978-94-011-0275-9
eBook Packages: Springer Book Archive